On August 3rd, the Hunan Provincial Trademark and Brand Association released the "Announcement on the Recognition of the First Batch of Famous Brands in Hunan Province for 2023". The company's "Chunguang Jiuhui" brand was successfully selected. This marks the second famous brand achieved by the company, following the "Chaowei" trademark, and is a recognition of the company's dedication to the innovative development of new traditional Chinese medicine decoction pieces over the years.

The company is a secondary enterprise under the SASAC of Hunan Province, a modern traditional Chinese medicine manufacturing enterprise controlled by Hunan Pharmaceutical Development Group and with shares held by Hunan Provincial Institute of Traditional Chinese Medicine, etc.

The company has been recognized as a high-tech enterprise in Hunan Province, a key enterprise for listing, one of the top 100 enterprises in strategic emerging industries, a "specialized, refined, unique, and innovative" small giant enterprise, and a provincial-level enterprise technology center. The company's project "Research and Industrialization of Key Technologies for Chinese Medicine Ultrafine Powder" won the second prize of the National Science and Technology Progress Award, filling the gap in Hunan's traditional Chinese medicine industry in terms of national science and technology progress awards.

As of July 31st, the company has obtained production registrations for 443 varieties of traditional Chinese medicine formula granules and completed cross-provincial registrations in 30 provincial regions. Currently, both the number of registered varieties and the number of cross-provincial registrations rank first in the province.

The new production line for traditional Chinese medicine formula granules, which the company invested nearly 300 million yuan to build, was officially put into operation on November 23, 2022. With a designed production capacity of no less than 600 million bags per year, it is currently the largest production line for traditional Chinese medicine formula granules in the province, featuring the most advanced facilities and equipment. Currently, it is accelerating the release of its production capacity.

In the future, the company will further increase its R&D investment, continuously promote technological innovation, create a brand with quality, and promote development with its brand, striving to become a leading enterprise in the field of new traditional Chinese medicine decoction pieces.